These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8737961)

  • 1. Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin.
    Sesardic D; McLellan K; Ekong TA; Das RG
    Pharmacol Toxicol; 1996 May; 78(5):283-8. PubMed ID: 8737961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic botulinum type A toxin: factors affecting potency.
    Mclellan K; Das RE; Ekong TA; Sesardic D
    Toxicon; 1996 Sep; 34(9):975-85. PubMed ID: 8896190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations.
    Ekong TA; McLellan K; Sesardic D
    J Immunol Methods; 1995 Mar; 180(2):181-91. PubMed ID: 7714333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxin.
    Pearce LB; Borodic GE; Johnson EA; First ER; MacCallum R
    Toxicon; 1995 Feb; 33(2):217-27. PubMed ID: 7597725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE
    Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection.
    Wilder-Kofie TD; Lúquez C; Adler M; Dykes JK; Coleman JD; Maslanka SE
    Comp Med; 2011 Jun; 61(3):235-42. PubMed ID: 21819693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays.
    Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D
    Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxins.
    Torgeman A; Diamant E; Levin L; David AB; Epstein E; Girshengorn M; Mazor O; Rosenfeld R; Zichel R
    Vaccine; 2017 Dec; 35(52):7213-7216. PubMed ID: 29174678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-detection of cleaved SNAP-25 from differentiated mouse embryonic stem cells provides a sensitive assay for determination of botulinum A toxin and antitoxin potency.
    Yadirgi G; Stickings P; Rajagopal S; Liu Y; Sesardic D
    J Immunol Methods; 2017 Dec; 451():90-99. PubMed ID: 28943257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avian eyelid assay, a new diagnostic method for detecting botulinum neurotoxin serotypes A, B and E.
    Wang J; Gao S; Zhang Q; Kang L; Liu Y
    Toxicon; 2007 Jun; 49(7):1019-25. PubMed ID: 17367833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a clinical assay for botulinum neurotoxins through mass spectrometric detection.
    Hoyt KM; Barr JR; Hopkins AO; Dykes JK; Lúquez C; Kalb SR
    J Clin Microbiol; 2024 Jun; 62(6):e0162923. PubMed ID: 38687021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Semin Cutan Med Surg; 2001 Jun; 20(2):127-36. PubMed ID: 11474745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid in vivo assay method for type G botulinal toxin.
    Mayorga LS; de Centorbi OP; de Milan CC; Gimenez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):78-83. PubMed ID: 3307234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A; Alam SI; Dhaked RK; Singh L
    Indian J Med Res; 2006 Sep; 124(3):355-62. PubMed ID: 17085839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus and botulinum toxins block the release of acetylcholine from slices of rat striatum and from the isolated electric organ of Torpedo at different concentrations.
    Rabasseda X; Blasi J; Marsal J; Dunant Y; Casanova A; Bizzini B
    Toxicon; 1988; 26(4):329-36. PubMed ID: 3406945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination.
    Pellett S; Tepp WH; Toth SI; Johnson EA
    J Pharmacol Toxicol Methods; 2010; 61(3):304-10. PubMed ID: 20100585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin.
    Sesardic D; Leung T; Gaines Das R
    Biologicals; 2003 Dec; 31(4):265-76. PubMed ID: 14624797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.